Profound Medical (PROF) Asset Utilization Ratio (2025 - 2026)
Profound Medical's (PROF) quarterly Asset Utilization Ratio came in at 0.25 in Q1 2026, up 33.6% year-on-year from 0.18 in Q1 2025, and down 7.06% quarter-over-quarter from 0.26 in Q4 2025.
Profound Medical (PROF) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Profound Medical's Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.25 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 33.6% year-over-year to 0.25 in Q1 2026; TTM through Mar 2026 was 0.25, a 33.6% increase from a year earlier, with the FY2025 full-year figure at 0.22, up 16.53% from the prior year.
- Asset Utilization Ratio retreated to 0.25 in Q1 2026 per PROF's latest filing, from 0.26 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.32 in Q3 2025 and bottomed at 0.18 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn | 0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.26 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.22 |
| Mar 31, 2025 | 0.18 |